4 Insights on

• Reduced Pathogen Growth
• Improved Antibiotic Sensitivity
• Altered Pathogenic Bacterial Biomolecules
• Increased Antibiotic Sensitization

2 Insights on

• Reduced Intestinal Inflammation
• Improved Metabolic Health

1 Insight on

• Improved Immune Function

2 Insights on

• Reduced Psoriasis Symptoms
• Improved Psoriasis Severity

7 Insights on

• Increased Bifidobacteria Growth
• Enhanced Bifidobacterial Growth
• Modulation of Microbiota Activity
• Enhanced Growth of Bifidobacteria
• Increased Microbiota Engraftment
• Improved Microbiota Activity
• Enhanced Infant Gut Microbiota by Bifidobacterium lactis

4 Insights on

• Improved Intestinal Barrier Function
• Improved Immunologic Barrier Function
• Reduced Apoptosis of Jejunal Mucosal Cells
• Reduced Inflammation Levels

1 Insight on

• Yeast Migration from Intestine to Vagina

6 Insights on

• Reduced Total Cholesterol Levels
• Improved Glucose Tolerance
• Reduced Hepatic Fat Accumulation
• Reduced Blood Glucose Levels
• Reduced Adipose Tissue
• Reduced Adipose Tissue Mass

12 Insights on

• Improved Immune Response
• Improved Growth Performance
• Improved Immune Organ Development
• Reduced Odor-Causing Compound Concentrations
• Reduced Organ Injury from Escherichia coli
• Reduced Organ Injury from Heat Stress
• Increased Relative Weight of Immune Organs
• Alleviated Organ Injury from E. coli O78
• Alleviated Organ Injury from Heat Stress
• Reduced Organ Injury
• Alleviated Organ Injury
• Increased Organ Weights

5 Insights on

• Reduced Gingival Bleeding
• Increase in Persistent Diseased Sites
• Persistent Diseased Sites
• Increased Number of Persistent Diseased Sites
• Increased Number of Persisting Diseased Sites with Pocket Depth Greater than 4 mm

5 Insights on

• Reduced Pro-Inflammatory Cytokines
• Reduced Colon Tumor Incidence
• Reduced Colonic Mucosa Damage
• Increased Colon Barrier Biomarkers
• Increased Pro-apoptotic Factor Levels

1 Insight on

• Improved Bifidogenic Response

5 Insights on

• Reduced Pathogen Growth
• Reduced Pro-Inflammatory Mediator Production
• Reduced Colitis Development
• Reduced Inflammatory Parameters
• Elimination of Candida glabrata

7 Insights on

• Reduced Interleukin-6 Levels
• Improved Gut Microbiome
• Reduced Gut Barrier Defect
• Reduced TNF-α Levels
• Reduced Inflammation
• Improved Gut Barrier Function
• Reduced Gut Membrane Barrier Damage

3 Insights on

• Reduced Fever Duration
• Maintained Secretory IgA Levels
• Maintained Higher Salivary Immunoglobulin A Levels

3 Insights on

• Improved Exercise Performance
• No Adverse Food Reactions
• Unchanged Body Composition

3 Insights on

• Reduced Waist Circumference
• Reduced Body Fat Mass
• Absence of Serious Side Effects

1 Insight on

• Reduced Blood Ammonia Levels

2 Insights on

• Reduced Subjective Stress Levels
• Reduced Stress Levels

2 Insights on

• Improved Gut Microbiota Diversity
• Improved Bowel Movements

2 Insights on

• Increased Antioxidant Activity
• Reduced Metal Ion Burden

5 Insights on

• Improved Cognitive Function
• Reduced Depression Symptoms
• Improved Anxiety Symptoms
• Improved Depressive Symptoms
• Improved Somatic Symptoms

9 Insights on

• Reduced S. aureus Adhesion
• Reduced Enteropathogenic Escherichia coli (EPEC) Adhesion
• Reduced Pathogen Adhesion to Vaginal Epithelial Cells
• Inhibited Adhesion of Staphylococcus Aureus
• Enhanced Vaginal Epithelial Cell Adhesion
• Reduced Adhesion of Streptococcus agalactiae
• Reduced Adhesion of Gardnerella
• Inhibited Adhesion of Mobiluncus
• Reduced Adhesion of Enterococcus faecalis

1 Insight on

• Reduced Leukocyte Influx During C. Albicans Challenge

2 Insights on

• Reduced Diarrhea Incidence
• Reduced Diarrhea Symptoms

4 Insights on

• Improved Physical Performance
• No Human Health Outcome Reported
• Improved Physical and Cognitive Performance
• Improved Physical and Psychological Performance

13 Insights on

• Reduced Hepatic Oxidative Stress
• Reduced Small-Intestinal Damage
• Reduced Oxidative Stress
• Reduced Intestinal Damage
• Reduced Lipid Peroxidation
• Reduced Drug-Induced Intestinal Damage
• Partial Restoration of Intestinal Cell Proliferation
• Reduced Drug-Induced Enteropathy
• Reduced Enteropathy
• Improved Intestinal Cell Proliferation
• Improved Proliferative Capacity of Intestinal Cells
• Protected Intestinal Health
• Reduced Severity of Chemotherapy-Induced Enteropathy

2 Insights on

• Restored Goblet Cell Count
• Reduced Mucus Layer Thinning

3 Insights on

• Reduced Waist Circumference
• Reduced Body Mass Index
• Reduced Total Cholesterol

4 Insights on

• Improved Intestinal Barrier Function
• Reduced Pro-Inflammatory Mediator Production
• Improved Epithelial Barrier Integrity
• Reduced Inflammatory Response to Inflammatory Stimulus